Evidence map›Paper›PMID 35483404›Full record

ArticleNature2022

Inflammasome activation in infected macrophages drives COVID-19 pathology.

Esen Sefik, Rihao Qu, Caroline Junqueira, Eleanna Kaffe, Haris Mirza, Jun Zhao, J Richard Brewer, Ailin Han, Holly R Steach, Benjamin Israelow and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 348 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
348citing papers in PubMed, 1 pooled it
50.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

348 citing papers in PubMed, 1 synthesis or guideline pooled it, 516 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

288 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 2 countries.

Esen SefikDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-6807-3498
Rihao QuDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Caroline JunqueiraProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0545-0986
Eleanna KaffeDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Haris MirzaDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Jun ZhaoDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
J Richard BrewerDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Ailin HanDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Holly R SteachDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-0018-3129
Benjamin IsraelowDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-1308-8246
Holly N BlackburnDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Sofia E VelazquezDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-5954-3518
Y Grace ChenDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-3574-5734
Stephanie HaleneDepartment of Pathology, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-2737-9810
Akiko IwasakiDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-7824-9856
Eric MeffreDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-4326-0171
Michel NussenzweigLaboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.ORCID http://orcid.org/0000-0003-0592-8564
Judy LiebermanProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6200-4715
Craig B WilenDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-2495-9403
Yuval KlugerDepartment of Pathology, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-3035-071X
Richard A FlavellDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA. Richard.Flavell@yale.edu.ORCID http://orcid.org/0000-0003-4461-0778
Yale University · USHoward Hughes Medical Institute · USBoston Children's Hospital · USYale Cancer Center · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI MEGAN C KING · 1985 to 2026
$85.0M
Regulation of IgA class switching in the intestinal mucosaP01AI061093 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI CUNNINGHAM-RUNDLES, CHARLOTTE · 2004 to 2021
$29.8M
Yale Cooperative Hematology Specialized Core CenterU54DK106857 · NIDDK · YALE UNIVERSITY · PI JOHN HWA, Diane S Krause · 2015 to 2026
$9.7M
TRAINING IN THE PATHOGENESIS OF INFECTIOUS DISEASEST32AI007517 · NIAID · YALE UNIVERSITY · PI Jaimie Meyer, Albert C Shaw · 1997 to 2026
$6.1M
Viral and immune-mediated CNS pathology during SARS-CoV-2 infectionR01AI157488 · NIAID · YALE UNIVERSITY · PI FARHADIAN, SHELLI, IWASAKI, AKIKO · 2020 to 2024
$4.7M
The role of tuft cells in norovirus pathogenesisR01AI148467 · NIAID · YALE UNIVERSITY · PI Craig Brian Wilen · 2020 to 2026
$3.9M
Immuno-Serological Assays for Monitoring COVID19 in Patients with Hematologic MalignanciesU01CA260507 · NCI · YALE UNIVERSITY · PI FAN, RONG, HALENE, STEPHANIE · 2020 to 2024
$3.5M
The Regulation of Circular RNA FunctionsR35GM142687 · NIGMS · YALE UNIVERSITY · PI CHEN, YE GRACE · 2021 to 2025
$2.2M
Human Gut Commensal Cross-reactivity in Antiphospholipid SyndromeR01AI118855 · NIAID · YALE UNIVERSITY · PI KRIEGEL, MARTIN A., MEFFRE, ERIC · 2015 to 2019
$2.1M
EFFICIENT METHODS FOR CALIBRATION, CLUSTERING, VISUALIZATION AND IMPUTATION OF LARGE scRNA-seq DATAR01GM131642 · NIGMS · YALE UNIVERSITY · PI KLUGER, YUVAL · 2019 to 2022
$1.6M
Role of virus-receptor interactions in determining norovirus tropism and pathogenesis in vivoK08AI128043 · NIAID · YALE UNIVERSITY · PI WILEN, CRAIG BRIAN · 2017 to 2021
$940k
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR001863NCI NIH HHS F30 CA239444NCI NIH HHS P30 CA016359NCI NIH HHS U01 CA260507NIAID NIH HHS K08 AI128043NIAID NIH HHS P01 AI061093NIAID NIH HHS R01 AI118855NIAID NIH HHS R01 AI148467NIAID NIH HHS R01 AI157488NIAID NIH HHS T32 AI007517NIDDK NIH HHS U54 DK106857NIGMS NIH HHS R01 GM131642NIGMS NIH HHS R01 GM135928NIGMS NIH HHS R35 GM142687
6 · The paper itself

Abstract

Severe COVID-19 is characterized by persistent lung inflammation, inflammatory cytokine production, viral RNA and a sustained interferon (IFN) response, all of which are recapitulated and required for pathology in the SARS-CoV-2-infected MISTRG6-hACE2 humanized mouse model of COVID-19, which has a human immune system

Indexed as

COVID-19InflammasomesMacrophagesSARS-CoV-2Angiotensin-Converting Enzyme 2AnimalsHumansInterleukin-1Interleukin-18LungMiceNLR Family, Pyrin Domain-Containing 3 ProteinPneumoniaPyroptosisReceptors, IgGAngiotensin-Converting Enzyme 2InflammasomesInterleukin-1Interleukin-18NLR Family, Pyrin Domain-Containing 3 ProteinReceptors, IgG

Identifiers

PMID35483404
PMCPMC9288243
OpenAlexW4225159577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.